Chengdu High-tech Zone Kaiyuan Pharmaceutical

Chengdu High-tech Zone Kaiyuan Pharmaceutical is a specialized pharmaceutical company headquartered in Chengdu, China, focusing on the research, development, and production of high-end active pharmaceutical ingredients (APIs) and chemical intermediates. Established in 2008, the company has built a robust portfolio centered on small molecule therapeutics, particularly in the fields of anticoagulation, oncology, and metabolic diseases. Kaiyuan Pharmaceutical operates state-of-the-art R&D and manufacturing facilities that comply with international quality standards, enabling it to supply products to both domestic and global markets. The company is recognized for its expertise in complex chemical synthesis and its commitment to providing cost-effective generic alternatives for critical medications. Its product line includes notable agents such as Rivaroxaban, Apixaban, and Vildagliptin.